Cohort study: ECMO in patients with severe respiratory failure from COVID-19

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 – Intensive Care Medicine

Related: ECMO for COVID-19 patients in Europe and Israel – Intensive Care Medicine

Commentaries on Twitter

#ECMO in #COVID19, multicenter US based study on 5122 critical adults
➡️#ECLS in 3.7%, 66.8% of whom survived to hospital discharge or 60 days
➡️considerably reduced mortality with early ECMO in severe hypoxemic respiratory failure vs conventional approachhttps://t.co/OgS7Q5tctS pic.twitter.com/PO5O8t3l8F

— Intens Care Med (@yourICM) February 4, 2021

Online today @yourICM, our important multicenter descriptive and trial emulation work around #ECMO and #COVID19 @BIDMCAnesthesia @DavidLeaf9 @SamanthaSkb273 @_MiguelHernan from the STOP-COVID Investigators https://t.co/DuhWufYqZ3 pic.twitter.com/nXPvKDYMYL

— Shaz Shaefi (@SShaefi) February 2, 2021